Three Functions of Health Financing

Health financing is often discussed through country labels: tax-funded service, social insurance, private insurance, or mixed system. Those labels can hide more than they reveal. Every system must answer three operational questions. Where does the money come from? How is it pooled so that the person who becomes ill does not bear the whole cost at that moment? How are pooled resources used to pay for services?

The World Health Organization organizes these questions as revenue raising, pooling, and purchasing. The functions are linked. A country can raise substantial revenue yet fragment it into pools that cannot share risk. A broad pool can still purchase low-value care. Strategic purchasing cannot compensate for a revenue base too small to fund essential services.

Function one: raise revenue#

Revenue can come from general taxation, payroll contributions, and mandatory or voluntary premiums. It can come from employer contributions, external assistance, earmarked taxes, and direct household payments. Most countries use a mix.

The source shapes equity. A progressive contribution takes a larger share of resources from those with greater ability to pay. A regressive charge takes a larger share from lower-income households. The design of the overall tax and transfer system matters, not only the nominal rate attached to health.

Sufficiency asks whether revenue can support the promised benefit package, workforce, and medicines. It asks whether revenue can support facilities, public health, and administrative functions. Stability asks whether funds persist through economic downturns, epidemics, and political cycles. Predictability matters because health systems must hire staff and purchase supplies before illness occurs.

Earmarked taxes can make a funding stream visible and link harmful products with health goals, though they can also be volatile, narrow the budget's flexibility, or substitute for rather than add to general revenue. The effect depends on the fiscal system.

External assistance may be essential, particularly for low-income settings or global threats. Fragmented donor programs can create separate reporting systems and short funding horizons. Alignment with national priorities, budgets, and workforce plans determines whether funding strengthens or distorts the system.

Direct payment is revenue without much protection#

Out-of-pocket payment is what happens when you pay at the point of service. It raises money, but it does not create meaningful prepayment or risk sharing. The bill arrives at the moment illness has already cut your income or created other costs.

User fees can deter unnecessary use in theory. In practice, you often cannot tell low-value care from urgent care before someone assesses you. Charges can delay diagnosis, reduce medicine adherence, and impose financial hardship. Exemption programs may fail when eligibility is complex, stigmatizing, or poorly funded.

Financial protection is measured in several ways, including catastrophic health spending and impoverishing spending. Threshold definitions differ, so comparisons should state the denominator and method. Even spending below a formal threshold can force a household to sacrifice food, housing, education, or debt repayment. Cutting what people pay at the counter generally means moving that money upstream, into compulsory prepayment through taxes or mandatory contributions, alongside a coverage policy that states what is covered.

Function two: pool funds and risk#

Pooling accumulates prepaid resources on behalf of a population. People contribute according to financing rules, and funds are used according to health need rather than each person's immediate contribution.

Risk pooling redistributes from people who remain healthy during a period to those who need care. Income redistribution can move resources from richer to poorer households. Life-course redistribution moves resources across ages and health states.

Larger and more diverse pools can absorb unpredictable high-cost events better than small groups, and WHO advises reducing fragmentation or mitigating its consequences, aiming for larger pools with diverse risk and compulsory participation where feasible.

Voluntary pools face adverse selection: people expecting higher costs are more likely to enroll, while healthier people may stay out: premiums rise, coverage becomes unstable, and insurers may seek lower-risk members. Mandatory participation broadens the base but requires legitimate governance and affordable contribution rules.

Fragmentation limits redistribution#

Separate pools may be organized by employment, geography, income, insurer, or disease. Fragmentation can produce different benefit packages, prices, waiting times, and provider networks. People with greater needs may be concentrated in pools with fewer resources.

Risk adjustment transfers money according to expected need so a pool is not punished for enrolling older or sicker members; the formula may include age, diagnoses, disability, socioeconomic conditions, and geography. Weak adjustment leaves incentives to select favorable risks; aggressive coding can arise when diagnoses increase payment.

Cross-subsidies can also occur through central budget transfers or shared high-cost funds. Administrative consolidation is not the only route, but the mechanism must be strong enough to move resources across pool boundaries.

A national pool can still be inequitable if there is no provider where you live, or if the package excludes the service you need. Pooling creates purchasing power; service delivery determines whether that power becomes care.

Function three: purchase services#

Purchasing is the allocation of pooled resources to providers for specified or unspecified services, and it includes deciding which services are covered, which providers may deliver them, how prices are set, how payment occurs, and what information is required.

Passive purchasing pays historical budgets or submitted bills with limited connection to population need, quality, or outcomes. Strategic purchasing uses information to make active decisions: what to buy, from whom, and at what price. It also decides with which incentives and under which accountability. Strategic does not mean one payment formula. It means the method matches policy objectives and is monitored for unintended effects.

Provider payment changes behavior#

Fee-for-service pays for each visit, test, or procedure. It can support activity and access but may reward volume, fragmentation, and higher-intensity services.

Capitation pays a prospective amount per enrolled person for a defined set of services; it can encourage prevention and coordination but may create incentives to avoid high-need patients or provide too little care unless risk adjustment and quality monitoring are strong.

Salary supports predictable staffing and can reduce incentives for unnecessary volume. It may be insensitive to workload or access unless management and performance systems function well.

Diagnosis-related payment provides a set amount for a hospitalization category. It can encourage efficiency and shorter stays but can reward upcoding, selection, or premature discharge. Global budgets cap spending and provide flexibility while requiring decisions about demand and queues.

Blended payment can balance incentives. Every blend adds complexity and opportunities for gaming. Measures should be few, meaningful, risk-adjusted where appropriate, and resistant to displacement of unmeasured care.

Purchasing defines a benefit package#

No system funds every possible service without limit. Coverage policy defines which populations, services, medicines, and cost-sharing rules apply. Decisions may consider disease burden, effectiveness, and safety. They may consider cost-effectiveness, equity, and budget impact. They may consider feasibility and social values.

An explicit package can improve transparency. It also creates difficult boundary decisions. A service can be cost-effective yet unaffordable at scale. A rare-disease treatment can have a large budget impact despite few recipients. Prevention can produce benefits outside the health budget or years later.

Priority setting needs a public rationale, conflict-of-interest management, stakeholder participation, appeal, and revision as evidence changes. Hidden rationing through waiting, stockouts, or distance is still rationing, but less accountable. Primary care purchasing should account for continuity, comprehensiveness, coordination, and access rather than only discrete billable acts. Payment that rewards isolated procedures can underfund the relational work that prevents later harm.

Quality and access are part of the purchased product#

Nominal coverage means little when services are unavailable or harmful. Purchasing contracts can specify staffing, referral pathways, and medicine supply. They can specify reporting, patient safety, accessibility, and response times.

Pay-for-performance attaches money to selected measures. It can improve targeted processes but also encourage gaming, avoidance of complex patients, and neglect of unmeasured work. Small bonuses may not overcome workforce or supply constraints.

Quality measurement should combine structure, process, outcomes, experience, and equity. Mortality or readmission comparisons need case-mix adjustment, while adjustment should not hide disparities that policy aims to reduce. Providers need timely payment. Delayed public disbursement can produce stockouts, informal charges, and staff loss even when an approved budget exists.

Governance connects the functions#

Revenue, pooling, and purchasing depend on law and institutions. They depend on information, audit, and public trust. Governance defines who decides, who bears risk, how conflicts are managed, and what remedy exists when promises are not met.

Public financial management determines whether appropriated funds reach purchasers and providers in time. Procurement rules affect medicine prices and supply. Information systems connect enrollment, eligibility, claims, quality, and fraud control.

Administrative costs are not pure waste. Enrollment, payment, quality assurance, appeals, and fraud prevention require capacity. Fragmented systems can duplicate these functions, while underfunded administration can produce errors and inaccessible benefits. Transparency should reveal revenue sources, pool transfers, benefit rules, provider prices, and performance. Data without an understandable accountability route do not create governance by themselves.

The three functions form one causal chain#

Consider a new primary-care benefit. Revenue must be sufficient and progressive enough not to create hardship. Pooling must include the people with greatest need rather than isolating them. Purchasing must establish an accessible network, pay for longitudinal work, and monitor quality. Workforce and medicine supply must exist.

A failure at any link can look like another. Low service use may mean the copayment is unaffordable, the clinic is not there, the quality is poor, nobody trusts it, or the benefit was excluded, and from a spending table you cannot tell which. Raising more money will not solve every failure, but no purchasing reform can sustain unfunded promises.

The related article on social determinants of health examines nonfinancial barriers, while continuity of care shows why payment and delivery design matter to longitudinal care.

Compare systems by function, not branding#

For revenue, ask who contributes, how much, and how stable the funds are. For pooling, ask who shares risk, how fragmented pools are, and which transfers redistribute resources. For purchasing, ask what is covered, how providers are paid, and whether quality and access are measured.

Then examine outcomes: unmet need, effective coverage, and financial hardship. Examine equity, quality, and health. No system label answers those questions for you. The three-function framework makes the policy machinery visible enough to improve.

References#

1. WHO health financing overview
2. WHO pooling and fragmentation guidance
3. WHO health financing progress matrix
4. WHO and World Bank universal health coverage monitoring report
5. WHO strategic purchasing guidance
6. Health-system performance assessment, financing